Bank of America’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-86,796
| Closed | -$833K | – | 7476 |
|
|
2024
Q4 | $833K | Sell |
86,796
-30,547
| -26% | -$293K | ﹤0.01% | 4385 |
|
|
2024
Q3 | $336K | Buy |
117,343
+23,049
| +24% | +$65.9K | ﹤0.01% | 4889 |
|
|
2024
Q2 | $275K | Sell |
94,294
-90,072
| -49% | -$263K | ﹤0.01% | 4924 |
|
|
2024
Q1 | $588K | Sell |
184,366
-53,254
| -22% | -$170K | ﹤0.01% | 4461 |
|
|
2023
Q4 | $798K | Sell |
237,620
-104,851
| -31% | -$352K | ﹤0.01% | 4294 |
|
|
2023
Q3 | $815K | Buy |
342,471
+10,445
| +3% | +$24.9K | ﹤0.01% | 4162 |
|
|
2023
Q2 | $584K | Buy |
332,026
+79,878
| +32% | +$141K | ﹤0.01% | 4382 |
|
|
2023
Q1 | $777K | Buy |
252,148
+233,452
| +1,249% | +$719K | ﹤0.01% | 4345 |
|
|
2022
Q4 | $99.1K | Sell |
18,696
-7,587
| -29% | -$40.2K | ﹤0.01% | 5483 |
|
|
2022
Q3 | $92K | Buy |
26,283
+3,484
| +15% | +$12.2K | ﹤0.01% | 5566 |
|
|
2022
Q2 | $59K | Sell |
22,799
-8,950
| -28% | -$23.2K | ﹤0.01% | 5965 |
|
|
2022
Q1 | $143K | Sell |
31,749
-1,574
| -5% | -$7.09K | ﹤0.01% | 5899 |
|
|
2021
Q4 | $227K | Buy |
33,323
+4,088
| +14% | +$27.8K | ﹤0.01% | 5626 |
|
|
2021
Q3 | $213K | Buy |
29,235
+3,384
| +13% | +$24.7K | ﹤0.01% | 5428 |
|
|
2021
Q2 | $259K | Buy |
25,851
+10,534
| +69% | +$106K | ﹤0.01% | 5160 |
|
|
2021
Q1 | $146K | Buy |
15,317
+8,714
| +132% | +$83.1K | ﹤0.01% | 5568 |
|
|
2020
Q4 | $72K | Sell |
6,603
-3,967
| -38% | -$43.3K | ﹤0.01% | 5404 |
|
|
2020
Q3 | $93K | Buy |
+10,570
| New | +$93K | ﹤0.01% | 5118 |
|